Company intelligence / Profile preview

EdgePoint AI

Agoura Hills, California, United States

Ownership: Private
Development stage: Other

Overview

EdgePoint AI provides a cluster-computing AI platform tailored for pharmaceutical and biologics manufacturing, using hybrid vision machine learning and blockchain technologies to streamline operations, enhance data integrity, and reduce costs. This platform is currently deployed in collaborations with contract manufacturers to automate data capture and compliance processes. It is not a drug developer and does not have clinical stage assets itself, but its technology is implemented in pharma manufacturing environments.[1][2][3][5][11]

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

iBio

Beyond the preview

Go deeper on EdgePoint AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EdgePoint AI.

Explore the full profile